KYMR – kymera therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Kymera Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 [Yahoo! Finance]
Kymera Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Kymera Therapeutics to Participate in Upcoming February Investor Conferences [Yahoo! Finance]
Kymera Therapeutics to Participate in Upcoming February Investor Conferences
Kymera Therapeutics (NASDAQ:KYMR) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $138.00 price target on the stock.
Form 4 Kymera Therapeutics, For: Feb 20 Filed by: Esposito Pamela
Form 144 Kymera Therapeutics, Filed by: Esposito Pamela
Form SCHEDULE 13G/A Kymera Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
Form 4 Kymera Therapeutics, For: Jan 20 Filed by: Esposito Pamela
Form 144 Kymera Therapeutics, Filed by: Esposito Pamela
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.